Medtronic narrows 2013 guidance

Mon, 01/07/2013 - 1:44pm
Mass Device

Medical device company Medtronic cuts off the lower end of its fiscal year 2013 earnings-per-share guidance in consideration of a federal R&D tax credit.

Medtronic logo

Medical device giant Medtronic(NYSE:MDT) narrowed its fiscal year 2013 guidance today, citing new clarity on the impact of the federal R&D tax credit.

The Minnesota device maker now expects earnings-per-share in the range of $3.66-$3.70 for fiscal year 2013, from previous guidance in the range of $3.62-$3.70, CEO Omar Ishrak told an audience at the J.P. Morgan Healthcare conference in San Francisco today.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.